{"data":{"id":3146,"citation":"Andrews KM, Beebe DA, Benbow JW, Boyer DA, Doran SD, Hui Y, Liu S, McPherson RK, Neagu C, Parker JC, Piotrowski DW, Schneider SR, Treadway JL, VanVolkenberg MA, Zembrowski WJ.: 1-((3S,4S)-4-amino-1-(4-substituted-1,3,5-triazin-2-yl) pyrrolidin-3-yl)-5,5-difluoropiperidin-2-one inhibitors of DPP-4 for the treatment of type 2 diabetes. Bioorg Med Chem Lett, Volume 21 (6), 2011","title":"1-((3S,4S)-4-amino-1-(4-substituted-1,3,5-triazin-2-yl) pyrrolidin-3-yl)-5,5-difluoropiperidin-2-one inhibitors of DPP-4 for the treatment of type 2 diabetes.","doi":"10.1016\/j.bmcl.2011.01.055","doi_url":"https:\/\/doi.org\/10.1016\/j.bmcl.2011.01.055","pmid":"21324688","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/21324688\/","year":2011,"journal":"Bioorg Med Chem Lett","volume":"21","issue":"6","page":"1810-1814","authors":[{"first_name":"Andrews KM","last_name":null,"full_name":null},{"first_name":"Beebe DA","last_name":null,"full_name":null},{"first_name":"Benbow JW","last_name":null,"full_name":null},{"first_name":"Boyer DA","last_name":null,"full_name":null},{"first_name":"Doran SD","last_name":null,"full_name":null},{"first_name":"Hui Y","last_name":null,"full_name":null},{"first_name":"Liu S","last_name":null,"full_name":null},{"first_name":"McPherson RK","last_name":null,"full_name":null},{"first_name":"Neagu C","last_name":null,"full_name":null},{"first_name":"Parker JC","last_name":null,"full_name":null},{"first_name":"Piotrowski DW","last_name":null,"full_name":null},{"first_name":"Schneider SR","last_name":null,"full_name":null},{"first_name":"Treadway JL","last_name":null,"full_name":null},{"first_name":"VanVolkenberg MA","last_name":null,"full_name":null},{"first_name":"Zembrowski WJ.","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/3146","landing_page":"https:\/\/molmedb.upol.cz\/publication\/3146","created_at":"2024-05-21T09:16:04.000000Z","updated_at":null}}